innogy SE

  • WKN: A2AADD
  • ISIN: DE000A2AADD2
  • Land: Deutschland

Nachricht vom 08.11.2018 | 19:41

innogy SE: Terms of the proposed transaction to combine innogy's and SSE's retail businesses in Great Britain require adjustments

innogy SE / Key word(s): Mergers & Acquisitions/Joint Venture
innogy SE: Terms of the proposed transaction to combine innogy's and SSE's retail businesses in Great Britain require adjustments

08-Nov-2018 / 19:41 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Due to adverse developments in the market and regulatory interventions, innogy SE and SSE plc decided to enter into negotiations on adjustments of the terms regarding the combination of their retail businesses in Great Britain as announced in November 2017. This may also result in additional direct or indirect financial contributions by each party. The parties currently still pursue the objective to combine their respective businesses and to enable the listing of the new company on the London Stock Exchange. The details of the required adjustments and their impact on the transaction structure as well as on the timing are still being analyzed and discussed.

Responsible person: Dr. Claudia Mayfeld, General Counsel of innogy SE


08-Nov-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

UniDevice AG: Rekord-Ergebnis in 2018

Nach starkem Schlussspurt hat die UniDevice AG in 2018 Umsatz und Ergebnis deutlich gesteigert. Der B2B-Broker für hochpreisige Smartphones sollte auch künftig eine hohe Nachfrage verzeichnen und von der Ausnutzung unterschiedlicher Preisniveaus in den verschiedenen Ländern profitieren. Der Umsatz soll 2019 auf mindestens 380 Mio. € und in 2020 auf mindestens 410 Mio. € ansteigen, nachdem 2018 317 Mio. € erreicht wurden. Bei einem ermittelten Kursziel in Höhe von 2,35 € lautet das Rating KAUFEN.

News im Fokus

Linde plc: Linde plc Investor & Media Conference Call - Information

22. Februar 2019, 19:38

Aktueller Webcast

Ströer SE & Co. KGaA

Vorläufige Geschäftszahlen 2018

26. Februar 2019

Aktuelle Research-Studie

Sanochemia Pharmazeutika AG

Original-Research: Sanochemia Pharmazeutika AG (von Sphene Capital GmbH): Buy

21. Februar 2019